Validation of a novel direct method to determine reduced adherence to atorvastatin therapy
European Heart Journal - Cardiovascular Pharmacotherapy · 16.07.2024 · 10 (4) · 307-315
DOI: 10.1093/ehjcvp/pvae001 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, online erschienen am 09.01.2024. Verfasst von Jonas Pivoriunas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Postboks 800, Drammen 3004, Norway. Hauptthemen laut MEDLINE: Atorvastatin, Medication Adherence, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Department of Medicine, Drammen Hospital, Vestre Viken Trust.
Abstract (Originalsprache)
Aims
Objective methods to determine statin adherence are requested to improve lipid management. We have recently established a method to detect reduced adherence to atorvastatin therapy with cut-off values based on the sum of atorvastatin and its major metabolites in the blood. We aimed to validate this method in patients with and without cardiovascular disease, and optimize previous cut-off values. Methods and results The pharmacokinetic study included 60 participants treated with atorvastatin 20 mg (N = 20), 40 mg (N = 20), and 80 mg (N = 20). Atorvastatin was then stopped and blood samples collected from day zero to day four. Quantification of the parent drug and its metabolites in blood plasma was performed with a liquid chromatography-tandem mass spectrometry assay. The cut-off values for reduced adherence were validated and optimized by calculating diagnostic sensitivity and specificity. Our candidate cut-off value of dose-normalized six-component sum of atorvastatin plus metabolites <0.10 nM/mg provided a sensitivity of 97% and a specificity of 93% for detecting ≥2 omitted doses. An optimized cut-off <0.062 nM/mg provided a sensitivity of 90% and a specificity of 100%. An alternative simplified two-component metabolite sum with a cut-off value <0.05 nM/mg provided a sensitivity of 98% and a specificity of 76%. An optimized cut-off <0.02 nM/mg provided a sensitivity of 97% and a specificity of 98%.
Conclusion
This validation study confirms that our direct method discriminates reduced adherence from adherence to atorvastatin therapy with high diagnostic accuracy. The method may improve lipid management in clinical practice and serve as a useful tool in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Postboks 800, Drammen 3004, Norway.
- Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Domus Medica, Sognsvannsveien 9, Oslo 0372, Norway.
- Department of Pharmacology, Oslo University Hospital, Oslo 0372, Norway.
- Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo 0372, Norway.
- Oslo University Hospital, Ullevål Hospital, Oslo 0450, Norway.
ORCID-Profile: Jonas Pivoriunas, Nils Tore Vethe, Einar Husebye, Morten W Fagerland, Stein Bergan, Oscar Kristiansen, John Munkhaugen, Elise Sverre
Förderung
- Department of Medicine, Drammen Hospital
- Vestre Viken Trust
Zitieren
APA
Pivoriunas, J., Vethe, N. T., Husebye, E., Fagerland, M. W., Bergan, S., Kristiansen, O., Munkhaugen, J., & Sverre, E. (2024). Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European Heart Journal - Cardiovascular Pharmacotherapy, 10(4), 307-315. https://doi.org/10.1093/ehjcvp/pvae001
Vancouver
Pivoriunas J, Vethe NT, Husebye E, Fagerland MW, Bergan S, Kristiansen O, et al. Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European Heart Journal - Cardiovascular Pharmacotherapy. 2024;10(4):307-315. doi:10.1093/ehjcvp/pvae001
BibTeX
@article{Pivoriunas2024,
author = {Pivoriunas, Jonas and Vethe, Nils Tore and Husebye, Einar and Fagerland, Morten W and Bergan, Stein and Kristiansen, Oscar and Munkhaugen, John and Sverre, Elise},
title = {Validation of a novel direct method to determine reduced adherence to atorvastatin therapy},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2024},
volume = {10},
number = {4},
pages = {307--315},
doi = {10.1093/ehjcvp/pvae001}
}
EUVIMED